Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study.

Caminiti G, Volterrani M, Iellamo F, Marazzi G, Massaro R, Miceli M, Mammi C, Piepoli M, Fini M, Rosano GM.

J Am Coll Cardiol. 2009 Sep 1;54(10):919-27. doi: 10.1016/j.jacc.2009.04.078.

2.
3.

Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study.

Stout M, Tew GA, Doll H, Zwierska I, Woodroofe N, Channer KS, Saxton JM.

Am Heart J. 2012 Dec;164(6):893-901. doi: 10.1016/j.ahj.2012.09.016.

PMID:
23194490
4.

Effects of growth hormone on exercise capacity and cardiopulmonary performance in patients with chronic heart failure.

Fazio S, Palmieri EA, Affuso F, Cittadini A, Castellano G, Russo T, Ruvolo A, Napoli R, Saccà L.

J Clin Endocrinol Metab. 2007 Nov;92(11):4218-23.

PMID:
17698902
5.

The 12-week progressive quadriceps resistance training improves muscle strength, exercise capacity and quality of life in patients with stable chronic heart failure.

Jankowska EA, Wegrzynowska K, Superlak M, Nowakowska K, Lazorczyk M, Biel B, Kustrzycka-Kratochwil D, Piotrowska K, Banasiak W, Wozniewski M, Ponikowski P.

Int J Cardiol. 2008 Oct 30;130(1):36-43.

PMID:
18054809
6.

Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.

Blackman MR, Sorkin JD, Münzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, Jayme J, O'Connor KG, Christmas C, Tobin JD, Stewart KJ, Cottrell E, St Clair C, Pabst KM, Harman SM.

JAMA. 2002 Nov 13;288(18):2282-92.

PMID:
12425705
7.

Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.

Ponikowski P, Anker SD, Szachniewicz J, Okonko D, Ledwidge M, Zymlinski R, Ryan E, Wasserman SM, Baker N, Rosser D, Rosen SD, Poole-Wilson PA, Banasiak W, Coats AJ, McDonald K.

J Am Coll Cardiol. 2007 Feb 20;49(7):753-62.

8.

Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles.

Hambrecht R, Niebauer J, Fiehn E, Kälberer B, Offner B, Hauer K, Riede U, Schlierf G, Kübler W, Schuler G.

J Am Coll Cardiol. 1995 May;25(6):1239-49.

9.

Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure.

Jankowska EA, Filippatos G, Ponikowska B, Borodulin-Nadzieja L, Anker SD, Banasiak W, Poole-Wilson PA, Ponikowski P.

J Card Fail. 2009 Jun;15(5):442-50. doi: 10.1016/j.cardfail.2008.12.011.

PMID:
19477405
10.

Testosterone: a novel therapeutic approach in chronic heart failure?

Aukrust P, Ueland T, Gullestad L, Yndestad A.

J Am Coll Cardiol. 2009 Sep 1;54(10):928-9. doi: 10.1016/j.jacc.2009.05.039. No abstract available.

11.

Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.

von Haehling S, Schefold JC, Jankowska EA, Springer J, Vazir A, Kalra PR, Sandek A, Fauler G, Stojakovic T, Trauner M, Ponikowski P, Volk HD, Doehner W, Coats AJ, Poole-Wilson PA, Anker SD.

J Am Coll Cardiol. 2012 Feb 7;59(6):585-92. doi: 10.1016/j.jacc.2011.10.880.

12.

Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.

Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A, Androne AS.

Circulation. 2003 Jan 21;107(2):294-9.

13.

Relationship between isokinetic muscle strength and exercise capacity in chronic heart failure.

Clark A, Rafferty D, Arbuthnott K.

Int J Cardiol. 1997 Apr 18;59(2):145-8.

PMID:
9158166
14.

Skeletal muscle function and its relation to exercise tolerance in chronic heart failure.

Harrington D, Anker SD, Chua TP, Webb-Peploe KM, Ponikowski PP, Poole-Wilson PA, Coats AJ.

J Am Coll Cardiol. 1997 Dec;30(7):1758-64.

15.

The effect of metformin on insulin resistance and exercise parameters in patients with heart failure.

Wong AK, Symon R, AlZadjali MA, Ang DS, Ogston S, Choy A, Petrie JR, Struthers AD, Lang CC.

Eur J Heart Fail. 2012 Nov;14(11):1303-10. doi: 10.1093/eurjhf/hfs106. Review.

16.

Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men.

Storer TW, Woodhouse L, Magliano L, Singh AB, Dzekov C, Dzekov J, Bhasin S.

J Am Geriatr Soc. 2008 Nov;56(11):1991-9. doi: 10.1111/j.1532-5415.2008.01927.x.

17.

Effects of acute salbutamol inhalation on quadriceps force and fatigability.

Decorte N, Verges S, Flore P, Guinot M, Wuyam B.

Med Sci Sports Exerc. 2008 Jul;40(7):1220-7. doi: 10.1249/MSS.0b013e31816b87aa.

PMID:
18580400
18.

Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial.

Malkin CJ, Pugh PJ, West JN, van Beek EJ, Jones TH, Channer KS.

Eur Heart J. 2006 Jan;27(1):57-64.

19.

A randomized double-blind trial of enalapril in older patients with heart failure and preserved ejection fraction: effects on exercise tolerance and arterial distensibility.

Kitzman DW, Hundley WG, Brubaker PH, Morgan TM, Moore JB, Stewart KP, Little WC.

Circ Heart Fail. 2010 Jul;3(4):477-85. doi: 10.1161/CIRCHEARTFAILURE.109.898916.

20.

Anabolic status and functional impairment in men with mild chronic heart failure.

Pastor-Pérez FJ, Manzano-Fernández S, Garrido Bravo IP, Nicolás F, Tornel PL, Lax A, de la Morena G, Valdés M, Pascual-Figal DA.

Am J Cardiol. 2011 Sep 15;108(6):862-6. doi: 10.1016/j.amjcard.2011.05.016.

PMID:
21752346
Items per page

Supplemental Content

Support Center